Literature DB >> 1851662

p53 gene mutations in colorectal tumors from patients with familial polyposis coli.

S Shirasawa1, K Urabe, Y Yanagawa, K Toshitani, T Iwama, T Sasazuki.   

Abstract

The p53 gene has been elucidated as a tumor suppressor gene, and inactivation of this gene caused by deletion or point mutations may play a crucial role in the development of human malignancies. In colorectal carcinomas with an allelic deletion of the p53 gene, the remaining p53 gene was mutated with considerable frequency. It is most difficult to detect point mutations or small deletions of the gene because the mutations occur in diverse regions, although four hot spots have been observed [J.M. Nigro et al., Nature (Lond.), 342: 705-708, 1989]. The polymerase chain reaction and denaturing gradient gel electrophoresis facilitate detection of mutations in the hot spots of the p53 gene. Using these methods, we detected mutations in three adenomatous polyps and one carcinoma from familial polyposis coli patients and three carcinomas of sporadic cases. The DNA sequence analysis confirmed mutations of the p53 gene in 2 adenomas (13 base-pair deletions in one and a point mutation in the other) and 1 carcinoma (point mutation) from familial polyposis coli patients. These results suggest that the p53 gene mutations may be involved in the formation not only of carcinomas but also of adenomas which occur in familial polyposis coli patients.

Entities:  

Mesh:

Year:  1991        PMID: 1851662

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

Review 1.  Gastroduodenal lesions in familial adenomatous polyposis.

Authors:  H Kashiwagi; A D Spigelman
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

2.  Immunohistochemically detectable p53 and mdm-2 oncoprotein expression in colorectal carcinoma: prognostic significance.

Authors:  D Ofner; H Maier; B Riedmann; P Holzberger; M Nogler; M Tötsch; A Bankfalvi; G Winde; W Böcker; K W Schmid
Journal:  Clin Mol Pathol       Date:  1995-02

3.  P53 mutation in acute T cell lymphoblastic leukemia is of somatic origin and is stable during establishment of T cell acute lymphoblastic leukemia cell lines.

Authors:  J Yeargin; J Cheng; A L Yu; R Gjerset; M Bogart; M Haas
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

4.  Comparative analysis of p53 and c-myc expression and cell proliferation in human hepatocellular carcinomas--an enhanced immunohistochemical approach.

Authors:  M Saegusa; Y Takano; H Kishimoto; G Wakabayashi; K Nohga; M Okudaira
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

5.  Concurrent p53 expression in bronchial dysplasias and squamous cell lung carcinomas.

Authors:  K Nuorva; Y Soini; D Kamel; H Autio-Harmainen; L Risteli; J Risteli; K Vähäkangas; P Pääkkö
Journal:  Am J Pathol       Date:  1993-03       Impact factor: 4.307

6.  3,3'-diindolylmethane enhances the efficacy of butyrate in colon cancer prevention through down-regulation of survivin.

Authors:  Namrata Bhatnagar; Xia Li; Yue Chen; Xudong Zhou; Scott H Garrett; Bin Guo
Journal:  Cancer Prev Res (Phila)       Date:  2009-05-26

7.  Low frequency and late occurrence of p53 and dcc aberrations in colorectal tumours.

Authors:  N J Froggatt; S H Leveson; R C Garner
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

8.  Expression Profiling of Proliferation and Apoptotic Markers along the Adenoma-Carcinoma Sequence in Familial Adenomatous Polyposis Patients.

Authors:  Jayson Wang; Nabil El-Masry; Ian Talbot; Ian Tomlinson; Malcolm R Alison; Mona El-Bahrawy
Journal:  Gastroenterol Res Pract       Date:  2013-02-13       Impact factor: 2.260

9.  Gastric cancer with p53 overexpression has high potential for metastasising to lymph nodes.

Authors:  Y Kakeji; D Korenaga; S Tsujitani; H Baba; H Anai; Y Maehara; K Sugimachi
Journal:  Br J Cancer       Date:  1993-03       Impact factor: 7.640

10.  Two subtypes of colorectal tumor with distinct molecular features in familial adenomatous polyposis.

Authors:  Kiyoko Takane; Keisuke Matsusaka; Satoshi Ota; Masaki Fukuyo; Yao Yue; Motoi Nishimura; Eiji Sakai; Kazuyuki Matsushita; Hideaki Miyauchi; Hiroyuki Aburatani; Yukio Nakatani; Tadatoshi Takayama; Hisahiro Matsubara; Kiwamu Akagi; Atsushi Kaneda
Journal:  Oncotarget       Date:  2016-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.